SCHEMBL24309956

SCHEMBL24309956

CC1(C)CCC(c2cc(Oc3ccccc3)nc(N[S+]([O-])c3ccccc3)n2)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR39 O43194 1/20 0.35
▸ CYP1A2 P05177 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ NUDT1 P36639 1/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ SLC6A2 P23975 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31
▸ SLC6A3 Q01959 1/20 0.31
▸ HDAC8 Q9BY41 1/20 0.31
▸ HPGD P15428 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ MEN1 O00255 2/20 0.30
▸ KMT2A Q03164 2/20 0.30
▸ ATM Q13315 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29566782 0.78 TSHR (0.46) GPR39CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL24309955 0.78 TSHR (0.46) GPR39CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL24309988 0.72 GPR39 (0.43) GPR39CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL24309476 0.70 GPR39 (0.41) GPR39CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL26811032 0.66 TSHR (0.50) CYP1A2MAPTCYP2C9CYP2C19HPGD
SCHEMBL26811008 0.65 TSHR (0.46) GPR39CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL26811003 0.65 TSHR (0.48) CYP1A2MAPTCYP2C9CYP2C19HPGD
SCHEMBL24310334 0.64 WNT1 (0.32) GPR39CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL26811034 0.64 TSHR (0.47) CYP1A2MAPTCYP2C9CYP2C19MAPK1
SCHEMBL29566328 0.64 HTR1A (0.40) CYP1A2MAPTCYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback